Tender detail

Non-exclusive discount agreement for sevelamer hydrochloride medicines

Summary

DAK-Gesundheit is seeking non-exclusive pharmaceutical discount agreements for medicines containing the active substance sevelamer hydrochloride (ATC V03AE02). The agreements are scheduled to run from 1 January 2027 to 31 December 2028, with an option to extend for one further 12-month period, and will end earlier if an exclusive agreement takes effect.

Reference number
e3f5ed08-9dad-472e-88f0-1596238d942c
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2029-11-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.